Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients-Reference-Cited by-同舟云学术

Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients

Published:2004-06-07 Issue:2 Volume:34 Page:155-159
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Shapira M Y,Resnick I B,Bitan M,Ackerstein A,Samuel S,Elad S,Miron S,Zilberman I,Slavin S,Or R

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1704540.pdf

Reference21 articles.

1. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-vs-host disease in human recipients of marrow from HLA-matched-sibling donors. Transplantation 1974; 18: 295–304.

2. Pugatsch T, Oppenheim A, Slavin S . Improved single-step PCR assay for sex identification post-allogeneic sex-mismatched BMT. Bone Marrow Transplant 1996; 17: 273–275.

3. Nakamura Y, Leppert O, O’Connel P et al. Variable number of tandem repeats (VNTR) markets for human gene mapping. Science 1987; 235: 1616–1622.

4. Brodsky J . The challenges of success: the aging of Israeli society. Isr Med Assoc J 2003; 5: 375–378.

5. Slavin S, Nagler A, Naparstek E et al. Non-myeloablative transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non-malignant hematologic diseases. Blood 1998; 91: 756–763.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of melphalan plus fludarabine-conditioning regimen in elderly patients aged ⩾55 years with hematological malignancies;Bone Marrow Transplantation;2015-10-05

2. Allogeneic stem cell transplantation in patients above 55: suggestion for a further stratification of the HCT-CI;Journal of Cancer Research and Clinical Oncology;2014-06-26

3. Immunosenescence Does Not Abrogate Engraftment of Murine Allogeneic Bone Marrow;Transplantation;2013-06-27

4. Hematopoietic Stem Cell Transplantation in Elderly Patients with Myelodisplastic Syndrome and Acute Myelogenous Leukemia: Use of Busulfan/Fludarabine for Conditioning;Stem Cells and Cancer Stem Cells, Volume 10;2013

5. Reduced-Intensity Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation in Patients Over 60 Years: A Report from the SFGM-TC;Biology of Blood and Marrow Transplantation;2012-02